Vice Chair for Research @WCMCNeurology

New York
Joined August 2011
Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy: The ARCADIA RCT @hoomankamel @WeillCornell @WCMCNeurology & colleagues jamanetwork.com/journals/jam… …our Top Viewed this week at JAMA
1
4
8
2,064
I don't expect as many clicks. Positive stories always trail negative stories. But it was fun writing about a great story of science done well on @Sensible__Med Congrats @hoomankamel et al sensible-med.com/p/the-study…
2
8
2
60
90,892
Introducing R2T2, our portable MRI, the first of its kind in New York City! Bedside #MRI in our neuroICU for the sickest patients, the future of neurocritical care @nyphospital @WeillCornell @hoomankamel @judyhtchang @san_murthy @merkler_alex @WCMRadiology @WCMNeurosurgery
1
11
3
39
6,150
🙏Congrats @hoomankamel + team on a novel + high-quality #RCT tackling: might #Afib be an epiphenomenon of an atrial myopathy as the true cause of thromboemboli? #ARCADIA was negative, BUT, as per our editorial, don't close the 📖yet! @UCSFCardiology @JAMA_current
Amazing editorial @gregorymmarcus @JAMA_current As of now in ESUS patients antiplatelets to be used and not anticoagulation. jamanetwork.com/journals/jam…
9
1
21
13,263
Hooman Kamel retweeted
In patients with cryptogenic stroke and evidence of atrial cardiopathy without atrial fibrillation, apixaban did not significantly reduce recurrent stroke risk compared with aspirin. #ISC24 ja.ma/3Us1vde
2
39
3
105
20,661
Steven Warach presents the phase 2 START trial of timing of anticoagulation after AF related stroke. Results supportive of early DOAC start among patients with moderately severe stroke #isc24 ##ISC2024 @StrokeAHA_ASA @AHAScience
4
13
1,024
Phase 3 clinical trial finds that apixaban is no more effective than aspirin at preventing a second stroke in patients diagnosed with atrial cardiopathy. Findings from team led by @WCMCNeurology may help inform treatment for stroke patients. bit.ly/3SLwwXh
2
11
1,091
Richard Bernstein introduces an awesome new term — SCAFDAS, subclinical AF detected after stroke — in his debate presentation about loop recorders after stroke #ISC24 @StrokeAHA_ASA
4
1
23
1,836
Hooman Kamel retweeted
It’s official! The latest Continuum issue on Cerebrovascular Disease is online, and shipping! 🧠Latest on treatment and prevention of acute ischemic stroke 🧠Diagnosis and management of CV disorders (CVT, dissection, AVMs) 🧠Pediatric stroke Link: journals.lww.com/continuum/p…
8
86
11
374
63,214
Sneak peek at the #Cerebrovascular Disease issue, guest edited by Dr. Hooman Kamel (@hoomankamel), publishing April 11 at ContinuumJournal.com. @WeillCornell #stroke #neurology #MedEd #NeuroTwitter
3
30
7
110
44,754
Congratulations to @NealSParikhMD for being selected as recipient of the 2023 Michael Pessin stroke leadership award, to be presented at #AANAM Great work Neal! @hoomankamel @MitchElkind @IndianNeuroinUS @nsanar
6
7
1
39
11,012
Hooman Kamel retweeted
Great to be part of this incredible SAH session at #ISC23 with @NimaE, @LochMacdonald, #cenkayata @nvr_mgh, @SherryChou399, @Char237237, and Sepi Amin-Hanjani @AHAScience eppro02.ativ.me/appinfo.php?… – at Dallas, TX
5
22
2,057
Very pleased to see AHA awards committee rename the Stroke Mentoring award in honor of Dr Ralph Sacco. ⁦@AHAScience⁩ ⁦@MitchElkind⁩
6
4
47
4,759
Great to catch up with old friends IN PERSON @nih_strokenet during #ISC23. @AHAScience @sheth_kevin
1
1
19
1,604
Debate continues w @hoomankamel 's con position vs LAAO. He cites meta-analysis with a trend of ischemic events (don't look at the composite primary) favoring OAC. Also, criticizes limited historical data + sample sizes relative to AC data. & he shows off his car!! 😆🚗#ISC23
3
5
726
Amazing start to #ISC23 discussing advances in NeuroCardiology with this all-star group! @guroledip @SposatoL @hoomankamel @StrokeAHA_ASA @American_Heart @JenniferMajers1 @UMiamiHealth @StrokeMiami @UMiamiNeuro
1
11
1
62
4,853